Home
>
National Drug Code (NDC)
>
Trimethoprim
Trimethoprim - 40032-330-24 - (trimethoprim)
Drug Information of Trimethoprim
| Product NDC: | 40032-330 |
| Proprietary Name: | Trimethoprim |
| Non Proprietary Name: | trimethoprim |
| Active Ingredient(s): | 100 mg/1 & nbsp; trimethoprim |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Trimethoprim
| Product NDC: | 40032-330 |
| Labeler Name: | Novel Laboratories,Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091437 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110624 |
Package Information of Trimethoprim
| Package NDC: | 40032-330-24 |
| Package Description: | 100 TABLET in 1 BOTTLE (40032-330-24) |
NDC Information of Trimethoprim
| NDC Code | 40032-330-24 |
| Proprietary Name | Trimethoprim |
| Package Description | 100 TABLET in 1 BOTTLE (40032-330-24) |
| Product NDC | 40032-330 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | trimethoprim |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110624 |
| Marketing Category Name | ANDA |
| Labeler Name | Novel Laboratories,Inc. |
| Substance Name | TRIMETHOPRIM |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
